Results 151 to 160 of about 1,729,239 (300)
Single-Cell Glycomics of the Pancreatic Tumor Microenvironment: Technologies, Glyco-Immune Checkpoints, and Tumor-Immune Communication. [PDF]
Anh DXT, Tateno H.
europepmc +1 more source
La utilización de nuevos procedimientos de estudio permite actualmente el diagnóstico preoperatorioen un porcentaje altísimo de casos. Pero el diagnóstico precoz del cáncer de páncreas no se ha logrado, no pudiéndore aún detectar tumore, de pequeño tamaño.
Delgado, Bolívar +5 more
openaire +1 more source
A novel PLGA/PBAE polymer microparticle platform revolutionizes intermediate‐stage liver cancer treatment by co‐delivering panobinostat and IL‐12 via a single TACE‐like injection. This sustained‐release system overcomes tumor immunosuppression, triggers robust innate and adaptive immune responses, and establishes tertiary lymphoid structures ...
Hongzhe Yu +7 more
wiley +1 more source
A Rare Case of Solid Pseudopapillary Pancreatic Tumor Causing Abdominal Pain. [PDF]
Ryu A +5 more
europepmc +1 more source
Pancreatic Schwannoma: A Rare Pancreatic Tumor
Iwano, Kosuke +3 more
openaire +3 more sources
Scheme of the KLF9/WTAP/YTHDF2/m6A/CSF1R regulatory axis in osteoclastogenesis and estrogen‐deficient osteoporosis. WTAP‐mediated m6A modification of Csf1r mRNA governs osteoclastogenesis via a YTHDF2‐mediated pathway. Pathological upregulation of KLF9 drives Wtap transcription, leading to increased m6A deposition on the 3’‐UTR of Csf1r mRNA.
Chen Shen +14 more
wiley +1 more source
Stromal homeostasis-restoring "rocket-like" nanomedicine inhibited pancreatic tumor growth in vivo. [PDF]
Fu N +6 more
europepmc +1 more source
A Transformer‐based AI framework, DLINP, screens millions of compounds to identify Co68, a cobalt‐pincer organometallic complex that biases TLR4‐MD2 signaling toward antitumor interferon activation while suppressing inflammatory toxicity through an early TLR4‐SYK‐STAT1 axis.
Xuefei Guo +10 more
wiley +1 more source
Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM Trial. [PDF]
Smith JP +7 more
europepmc +1 more source
Corynoxine exerts potent broad‐spectrum anticancer activity by directly targeting NQO1. This interaction dissociates the oncogenic NQO1‐PTPA complex, releasing PTPA to robustly activate the tumor suppressor PP2A. Consequently, downstream Raf/MEK/ERK and PI3K/AKT signaling pathways are suppressed, downregulating c‐Myc and driving tumor regression ...
Guoqing Hou +6 more
wiley +1 more source

